212 related articles for article (PubMed ID: 17979982)
21. EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.
Schuster C; Baumert TF
J Hepatol; 2009 Jan; 50(1):222-4. PubMed ID: 19019480
[TBL] [Abstract][Full Text] [Related]
22. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
[TBL] [Abstract][Full Text] [Related]
23. Screening of small-molecule compounds as inhibitors of HCV entry.
Yang JP; Zhou D; Wong-Staal F
Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270
[TBL] [Abstract][Full Text] [Related]
24. Cellular receptors and HCV entry.
Flint M; Tscherne DM
Methods Mol Biol; 2009; 510():265-77. PubMed ID: 19009268
[TBL] [Abstract][Full Text] [Related]
25. Regulatory roles of cell surface sialylation in susceptibility to sphingomyelinase in human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Int J Oncol; 2005 Jul; 27(1):209-14. PubMed ID: 15942662
[TBL] [Abstract][Full Text] [Related]
26. Fluorescent annexin A1 reveals dynamics of ceramide platforms in living cells.
Babiychuk EB; Monastyrskaya K; Draeger A
Traffic; 2008 Sep; 9(10):1757-75. PubMed ID: 18694456
[TBL] [Abstract][Full Text] [Related]
27. Effect of cell polarization on hepatitis C virus entry.
Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.
Farquhar MJ; Harris HJ; Diskar M; Jones S; Mee CJ; Nielsen SU; Brimacombe CL; Molina S; Toms GL; Maurel P; Howl J; Herberg FW; van Ijzendoorn SC; Balfe P; McKeating JA
J Virol; 2008 Sep; 82(17):8797-811. PubMed ID: 18579596
[TBL] [Abstract][Full Text] [Related]
29. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
30. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I.
Kapadia SB; Barth H; Baumert T; McKeating JA; Chisari FV
J Virol; 2007 Jan; 81(1):374-83. PubMed ID: 17050612
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus entry into host cells.
Helle F; Dubuisson J
Cell Mol Life Sci; 2008 Jan; 65(1):100-12. PubMed ID: 17914604
[TBL] [Abstract][Full Text] [Related]
32. Dopamine release in PC12 cells is mediated by Ca(2+)-dependent production of ceramide via sphingomyelin pathway.
Jeon HJ; Lee DH; Kang MS; Lee MO; Jung KM; Jung SY; Kim DK
J Neurochem; 2005 Nov; 95(3):811-20. PubMed ID: 16135082
[TBL] [Abstract][Full Text] [Related]
33. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
34. Transbilayer movement of ceramide in the plasma membrane of live cells.
Mitsutake S; Igarashi Y
Biochem Biophys Res Commun; 2007 Aug; 359(3):622-7. PubMed ID: 17553461
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of ceramide-mediated CD95 clustering.
Grassmé H; Schwarz H; Gulbins E
Biochem Biophys Res Commun; 2001 Jun; 284(4):1016-30. PubMed ID: 11409897
[TBL] [Abstract][Full Text] [Related]
36. Biological aspects of ceramide-enriched membrane domains.
Grassmé H; Riethmüller J; Gulbins E
Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
38. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.
Marukian S; Jones CT; Andrus L; Evans MJ; Ritola KD; Charles ED; Rice CM; Dustin LB
Hepatology; 2008 Dec; 48(6):1843-50. PubMed ID: 19003912
[TBL] [Abstract][Full Text] [Related]
39. Release of ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human intestinal cells.
Field FJ; Chen H; Born E; Dixon B; Mathur S
J Clin Invest; 1993 Dec; 92(6):2609-19. PubMed ID: 8254018
[TBL] [Abstract][Full Text] [Related]
40. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
